1,000
Participants
Start Date
September 30, 1993
carmustine
cyclophosphamide
doxorubicin hydrochloride
melphalan
prednisone
radiation therapy
MRC Myelomatosis Trials Office, Birmingham
Lead Sponsor
Medical Research Council
OTHER_GOV